相似文献
1
Milrinone in Enterovirus 71 Brain Stem Encephalitis.
Front Pharmacol. 2016 Mar 29;7:82. doi: 10.3389/fphar.2016.00082. eCollection 2016.
2
Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis.
Clin Dev Immunol. 2012;2012:876241. doi: 10.1155/2012/876241. Epub 2012 Aug 23.
3
Enterovirus 71 infection and neurological complications.
Korean J Pediatr. 2016 Oct;59(10):395-401. doi: 10.3345/kjp.2016.59.10.395. Epub 2016 Oct 17.
4
Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema.
Pediatr Pulmonol. 2005 Mar;39(3):219-23. doi: 10.1002/ppul.20157.
5
Enterovirus 71: epidemiology, pathogenesis and management.
Expert Rev Anti Infect Ther. 2009 Aug;7(6):735-42. doi: 10.1586/eri.09.45.
6
The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection.
PLoS One. 2014 Jul 10;9(7):e102025. doi: 10.1371/journal.pone.0102025. eCollection 2014.
7
[Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
Zhonghua Er Ke Za Zhi. 2005 Sep;43(9):648-52.
8
9
Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial.
Trials. 2016 Feb 19;17:98. doi: 10.1186/s13063-016-1215-6.
10
[Severe cases with hand, foot and mouth disease: data based on national pilot hand, foot and mouth disease surveillance system].
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jun 10;38(6):759-762. doi: 10.3760/cma.j.issn.0254-6450.2017.06.014.
引用本文的文献
1
Effects of adjunctive milrinone versus placebo on hemodynamics in patients with septic shock: a randomized controlled trial.
Ann Med. 2025 Dec;57(1):2484464. doi: 10.1080/07853890.2025.2484464. Epub 2025 Mar 26.
2
Blocking CCL3-mediated neutrophil recruitment into the brain alleviates immunopathology following severe enterovirus 71 infection.
iScience. 2024 Nov 15;27(12):111388. doi: 10.1016/j.isci.2024.111388. eCollection 2024 Dec 20.
3
Cordycepin Inhibits Enterovirus A71 Replication and Protects Host Cell from Virus-Induced Cytotoxicity through Adenosine Action Pathway.
Viruses. 2024 Feb 24;16(3):352. doi: 10.3390/v16030352.
4
Current status of hand-foot-and-mouth disease.
J Biomed Sci. 2023 Feb 24;30(1):15. doi: 10.1186/s12929-023-00908-4.
5
Drug Repositioning for Hand, Foot, and Mouth Disease.
Viruses. 2022 Dec 27;15(1):75. doi: 10.3390/v15010075.
6
Interplays between Enterovirus A71 and the innate immune system.
J Biomed Sci. 2019 Dec 2;26(1):95. doi: 10.1186/s12929-019-0596-8.
7
A case report of a teenager with severe hand, foot, and mouth disease with brainstem encephalitis caused by enterovirus 71.
BMC Pediatr. 2019 Feb 13;19(1):59. doi: 10.1186/s12887-019-1428-4.
8
A pathophysiological role of PDE3 in allergic airway inflammation.
JCI Insight. 2018 Jan 25;3(2). doi: 10.1172/jci.insight.94888.
9
Efficacy of for the Treatment of Hand, Foot, and Mouth Disease Associated with Encephalitis in Patients Infected with EV71: A Multicenter, Retrospective Analysis.
Biomed Res Int. 2016;2016:5697571. doi: 10.1155/2016/5697571. Epub 2016 Oct 20.
本文引用的文献
1
Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71.
PLoS One. 2015 Aug 7;10(8):e0135154. doi: 10.1371/journal.pone.0135154. eCollection 2015.
2
Sepsis, venous return, and teleology.
Med Hypotheses. 2014 Nov;83(5):545-8. doi: 10.1016/j.mehy.2014.09.001. Epub 2014 Sep 10.
3
The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection.
PLoS One. 2014 Jul 10;9(7):e102025. doi: 10.1371/journal.pone.0102025. eCollection 2014.
4
Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine.
Expert Rev Anti Infect Ther. 2014 Apr;12(4):447-56. doi: 10.1586/14787210.2014.895666. Epub 2014 Mar 3.
5
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
JAMA. 2013 Oct 23;310(16):1683-91. doi: 10.1001/jama.2013.278477.
6
Control of inflammatory heart disease by CD4+ T cells.
Ann N Y Acad Sci. 2013 May;1285:80-96. doi: 10.1111/nyas.12134.
7
Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial.
Crit Care Med. 2013 Jul;41(7):1754-60. doi: 10.1097/CCM.0b013e31828a2a85.
8
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Circ J. 2012;76(7):1646-53. doi: 10.1253/circj.cj-12-0033. Epub 2012 Apr 5.
9
The role of milrinone in children with cardiovascular compromise: review of the literature.
Wien Med Wochenschr. 2011 Apr;161(7-8):184-91. doi: 10.1007/s10354-011-0869-7. Epub 2011 Mar 7.
10
Modulating effects of nonselective and selective phosphodiesterase inhibitors on lymphocyte subsets and humoral immune response in mice.
Pharmacol Rep. 2010 Nov-Dec;62(6):1148-58. doi: 10.1016/s1734-1140(10)70377-7.
Zotero 插件